Merck & Co., Inc. (MRK)
148.35
-1.19
(-0.80%)
USD |
NYSE |
Aug 28, 16:00
148.20
-0.15
(-0.10%)
Pre-Market: 20:00
Merck Cash and Short Term Investments (Quarterly) : 7.182B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.182B |
| March 31, 2026 | 5.773B |
| December 31, 2025 | 14.69B |
| September 30, 2025 | 18.25B |
| June 30, 2025 | 8.665B |
| March 31, 2025 | 9.331B |
| December 31, 2024 | 13.76B |
| September 30, 2024 | 14.64B |
| June 30, 2024 | 11.40B |
| March 31, 2024 | 5.711B |
| December 31, 2023 | 7.161B |
| September 30, 2023 | 8.812B |
| June 30, 2023 | 6.422B |
| March 31, 2023 | 10.42B |
| December 31, 2022 | 13.27B |
| September 30, 2022 | 11.38B |
| June 30, 2022 | 10.21B |
| March 31, 2022 | 8.986B |
| December 31, 2021 | 8.096B |
| September 30, 2021 | 10.02B |
| June 30, 2021 | 8.575B |
| March 31, 2021 | 6.981B |
| December 31, 2020 | 8.05B |
| September 30, 2020 | 7.356B |
| June 30, 2020 | 11.10B |
| Date | Value |
|---|---|
| March 31, 2020 | 7.432B |
| December 31, 2019 | 10.45B |
| September 30, 2019 | 8.018B |
| June 30, 2019 | 7.105B |
| March 31, 2019 | 8.798B |
| December 31, 2018 | 8.864B |
| September 30, 2018 | 10.28B |
| June 30, 2018 | 7.594B |
| March 31, 2018 | 7.346B |
| December 31, 2017 | 8.498B |
| September 30, 2017 | 11.20B |
| June 30, 2017 | 11.97B |
| March 31, 2017 | 15.25B |
| December 31, 2016 | 14.34B |
| September 30, 2016 | 13.07B |
| June 30, 2016 | 11.83B |
| March 31, 2016 | 12.94B |
| December 31, 2015 | 13.43B |
| September 30, 2015 | 12.09B |
| June 30, 2015 | 11.37B |
| March 31, 2015 | 15.60B |
| December 31, 2014 | 15.72B |
| September 30, 2014 | 14.35B |
| June 30, 2014 | 13.40B |
| March 31, 2014 | 20.51B |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Johnson & Johnson | 20.76B |
| Eli Lilly & Co. | 8.95B |
| Pfizer Inc. | 11.70B |
| Bristol Myers Squibb Co. | 11.07B |
| Abbott Laboratories | 5.603B |